This case addresses two primary issues (i) whether the district court erred in construing the claim term “composition” in FMC’s pesticide patents to mean only “stable compositions,” based on disclosures found in a provisional application and a related patent, even though the asserted patents contained no stability language and (ii) whether the district court misapplied the preliminary injunction standard in rejecting Sharda’s anticipation and obviousness defenses.
Latest Post
More Posts
Federal Circuit Reins In Prosecution Disclaimer in Maquet v. Abiomed
No Mulligans: Frivolous Post-Judgment Motion Triggers § 1927 Sanctions After § 285 Award
Navigating Declaratory Judgment: Mitek’s Bid to Head Off USAA’s Patent Claims
Biopharmaceutical Patent Litigation: Regeneron’s Defense Against Biosimilar Launches
Koss Corporation v. Bose Corporation
Clearing the Path Forward: The Critical Role of Patent Searches
The Double-Edged Sword of AI in Patent Drafting and Prosecution
Precluded, Not Repeated: WARF & Apple Continue to Shape our Understanding of Issue Preclusion in Patent Law
Interpreting the Printed Matter Doctrine in Inter Partes Review
Subscribe: Subscribe via RSS